Literature DB >> 1315254

Gastrin-releasing peptide stimulation of corticotropin secretion in male rats.

L Olsen1, U Knigge, J Warberg.   

Abstract

Gastrin-releasing peptide (GRP; mammalian bombesin) may be involved in the neuroendocrine regulation of pituitary hormone secretion. We investigated the effect of GRP on ACTH secretion in conscious male rats. GRP (7-700 pmol) stimulated ACTH secretion dose-dependently after intracerebroventricular (icv) administration but had no effect after iv administration. GRP infused icv in a dose of 7 pmol, which alone increased ACTH 1.5-fold, potentiated the ACTH-releasing effect of arginine vasopressin (AVP; 80 pmol iv) and corticotropin-releasing hormone (CRH; 100 pmol iv). A higher dose of GRP (70 pmol icv), which stimulated ACTH secretion 2-fold, potentiated the effect of 80 and 400 pmol AVP iv, but had only additive effect on the ACTH response to 800 pmol AVP iv or 100 pmol CRH iv. GRP infused iv in a dose of 210 pmol, which in itself had no effect on ACTH secretion, potentiated the ACTH-stimulating effect of AVP and CRH approximately 2.5-fold. The effect of GRP (icv or iv) on AVP or CRH-stimulated ACTH release was only slightly smaller than the effect of combined administration of AVP and CRH (80 + 100 pmol iv). The ACTH-stimulating effect of GRP (700 pmol icv) was inhibited about 60% by pretreatment with either CRH or AVP antiserum and prevented by combined pretreatment with the antisera. The results indicate that: 1) GRP affects ACTH secretion indirectly at a suprapituitary level--possibly in the hypothalamus--by stimulating the release of AVP and CRH to the pituitary portal blood; and 2) GRP acts directly at the pituitary level to augment the effect of AVP and CRH on the corticotrophs. We suggest that GRP is involved in the multifactorial regulation of ACTH secretion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315254     DOI: 10.1210/endo.130.5.1315254

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Expression of CRABP1, GRP, and RERG mRNA in clinically non-functioning and functioning pituitary adenomas.

Authors:  T Chile; M L Corrêa-Giannella; M A H Z Fortes; M D Bronstein; M B Cunha-Neto; D Giannella-Neto; R R Giorgi
Journal:  J Endocrinol Invest       Date:  2011-01-26       Impact factor: 4.256

2.  Accelerated thymic maturation and autoreactive T cells in bronchopulmonary dysplasia.

Authors:  Dennis Rosen; Jong-Hwan Lee; Frank Cuttitta; Fatema Rafiqi; Simone Degan; Mary E Sunday
Journal:  Am J Respir Crit Care Med       Date:  2006-03-30       Impact factor: 21.405

Review 3.  A diurnal rhythm of stimulatory input to the hypothalamo-pituitary-adrenal system as revealed by timed intrahypothalamic administration of the vasopressin V1 antagonist.

Authors:  A Kalsbeek; J J van Heerikhuize; J Wortel; R M Buijs
Journal:  J Neurosci       Date:  1996-09-01       Impact factor: 6.167

4.  Effects of gastrin-releasing peptide agonist and antagonist administered to the basolateral nucleus of the amygdala on conditioned fear in the rat.

Authors:  Christine Mountney; Hymie Anisman; Zul Merali
Journal:  Psychopharmacology (Berl)       Date:  2008-06-18       Impact factor: 4.530

5.  Hypothalamic gastrin-releasing peptide receptor mediates an antidepressant-like effect in a mouse model of stress.

Authors:  Lihua Yao; Jianxin Chen; Hexiang Chen; Dan Xiang; Can Yang; Ling Xiao; Wanhong Liu; Huiling Wang; Gaohua Wang; Fan Zhu; Zhongchun Liu
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

6.  Transcriptomic changes throughout post-hatch development in Gallus gallus pituitary.

Authors:  Elizabeth M Pritchett; Susan J Lamont; Carl J Schmidt
Journal:  J Mol Endocrinol       Date:  2016-11-17       Impact factor: 5.098

7.  Stress and eating: a dual role for bombesin-like peptides.

Authors:  Z Merali; S Graitson; J C Mackay; P Kent
Journal:  Front Neurosci       Date:  2013-10-25       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.